Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies

被引：0

作者：

Gupta, Gopal N. ^{[1
]}

Hart, Spencer ^{[1
]}

机构：

[1] Loyola Univ Med Ctr, Dept Urol, Urol Oncol, Maywood, IL 60153 USA

来源：

UROLOGY | 2020年 / 137卷

关键词：

D O I：

10.1016/j.urology.2019.10.043

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：131 / 132

页数：2

共 50 条

[41] Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer
Ghai, Sangeet
Klotz, Laurence
Pond, Gregory R.
Kebabdjian, Marlene
Downes, Michelle R.
Belanger, Eric C.
Moussa, Madeleine
van der Kwast, Theodorus H.
RADIOLOGY, 2024, 312 (01)
[42] Detection of Clinically Significant Prostatic Adenocarcinoma in Patients with Targeted MRI Guided Prostate Needle Core Biopsies: Critical Role in Patients on Active Surveillance
Geller, Rachel
Vey, Brianna L.
Nour, Sherif G.
Elfatairy, Kareem
Osunkoya, Adeboye O.
LABORATORY INVESTIGATION, 2017, 97 : 226A - 226A
[43] Detection of Clinically Significant Prostatic Adenocarcinoma in Patients with Targeted MRI Guided Prostate Needle Core Biopsies: Critical Role in Patients on Active Surveillance
Geller, Rachel
Vey, Brianna L.
Nour, Sherif G.
Elfatairy, Kareem
Osunkoya, Adeboye O.
MODERN PATHOLOGY, 2017, 30 : 226A - 226A
[44] External validation of a Multiparametric MRI volumetric model to predict the utility of systematic biopsies at the time of targeted biopsy
Ninivaggi, A.
Falagario, U. G.
Guzzi, F.
Mancini, V
Bettocchi, C.
Busetto, G. M.
Cormio, L.
Carrieri, G.
EUROPEAN UROLOGY, 2023, 83 : S128 - S128
[45] Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naive, previous negative biopsy patients and men undergoing active surveillance
Borghesi, Marco
Bianchi, Lorenzo
Barbaresi, Umberto
Vagnoni, Valerio
Corcioni, Beniamino
Gaudiano, Caterina
Fiorentino, Michelangelo
Giunchi, Francesca
Chessa, Francesco
Garofalo, Marco
Bertaccini, Alessandro
Angelini, Stefano
Ercolino, Amelio
Casablanca, Carlo
Droghetti, Matteo
Golfieri, Rita
Schiavina, Riccardo
MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (03): : 357 - 366
[46] ACTIVE SURVEILLANCE IN PROSTATE CANCER FOR PATIENTS WITH NON-SUSPICIOUS MRI AT ENTRY: CAN CONFIRMATORY BIOPSIES BE AVOIDED?
Olivier, Jonathan
Puech, Philippe
Fantoni, Jean-Christophe
Drumez, Elodie
Leroy, Xavier
Villers, Arnauld
JOURNAL OF UROLOGY, 2018, 199 (04): : E143 - E143
[47] OPTIMIZING USE OF MRI-US FUSION TARGETED BIOPSY: UPDATED EXPERIENCE IN 1639 COMBINED SYSTEMATIC AND TARGETED PROSTATE BIOPSIES
Meng, Xiaosong
Rosenkrantz, Andrew B.
Huang, Richard
Deng, Fang-Ming
Wysock, James S.
Huang, William C.
Lepor, Herbert
Taneja, Samir S.
JOURNAL OF UROLOGY, 2018, 199 (04): : E901 - E901
[48] The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer
Marliere, Francois
Puech, Philippe
Benkirane, Ahmed
Villers, Arnauld
Lemaitre, Laurent
Leroy, Xavier
Betrouni, Nacim
Ouzzane, Adil
WORLD JOURNAL OF UROLOGY, 2014, 32 (04) : 951 - 958
[49] The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer
François Marliere
Philippe Puech
Ahmed Benkirane
Arnauld Villers
Laurent Lemaitre
Xavier Leroy
Nacim Betrouni
Adil Ouzzane
World Journal of Urology, 2014, 32 : 951 - 958
[50] The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer - results from the SAMS trial
Carlsson, Stefan
Bratt, Ola
Kristiansson, Dushanka
Jaderling, Fredrik
SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (04) : 318 - 322

← 1 2 3 4 5 →